Star Combo Pharma Ltd has released a press release.
Appendix 4D Half Yearly Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Story so far
Earlier from Star Combo Pharma
- $11m Transformational Investment
- Purchase of 65 Woodpark Road
- Star Combo Acquisition of iNature Option not exercised
- Star Combo Completes $33.3m Placement at $0.68 per share
- S66 ASX Appendix 3B
Later from Star Combo Pharma
- S66 1H21 Result Announcement
- Quarterly Business Update
- S66 OEM Order - Supplementary Announcement
- S66 - CEO Presentation to 2021 AGM
- S66 - Q2 FY22 Business Update
Follow Star Combo Pharma into a list and get an email when it puts out news.
Follow Star Combo Pharma